Home NDC 53002-0081 Acyclovir
Product NDC 53002-0081
11-digit product format 530020081
Labeler code 53002
Product ID 53002-0081_d8313650-50c3-4889-af0f-258cc032b028
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form TABLET
Route ORAL
Labeler RPK Pharmaceuticals, Inc.
Application ANDA202168
Marketing category ANDA
Marketing start 2016-10-15
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 400 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record FDA-Initiated Inactive NDC Indexing# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 53002-0081-1 53002008101 15 TABLET in 1 BOTTLE (53002-0081-1) 15 tablet 2018-10-01 0000-00-00 No No Current 53002-0081-2 53002008102 20 TABLET in 1 BOTTLE (53002-0081-2) 20 tablet 2018-10-01 0000-00-00 No No Current 53002-0081-3 53002008103 21 TABLET in 1 BOTTLE (53002-0081-3) 21 tablet 2018-10-01 0000-00-00 No No Current 53002-0081-4 53002008104 30 TABLET in 1 BOTTLE (53002-0081-4) 30 tablet 2018-10-01 0000-00-00 No No Current 53002-0081-5 53002008105 35 TABLET in 1 BOTTLE (53002-0081-5) 35 tablet 2018-10-01 0000-00-00 No No Current 53002-0081-6 53002008106 50 TABLET in 1 BOTTLE (53002-0081-6) 50 tablet 2018-10-01 0000-00-00 No No Current 53002-0081-9 53002008109 60 TABLET in 1 BOTTLE (53002-0081-9) 60 tablet 2018-10-01 0000-00-00 No No Current